GeneDx Holdings WGS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$21.02M— | —— | -$175.77M+68.0% | -$548.98M-124% | ||
| $25.22M+14.9% | $21.95M-34.9% | $33.73M-43.1% | $59.31M+172% | ||
| $32.16M+252% | $9.14M+2,903% | -$326K-101% | $41.98M-80.9% | ||
| —— | -$343K+63.0% | -$926K+98.1% | -$49.18M— | ||
| —— | $0-100% | $10.4M-95.1% | $210.15M— | ||
| $36.23M— | —— | -$10.73M-94.1% | -$5.53M— | ||
| —— | —— | -$975K+58.5% | -$2.35M— | ||
| —— | —— | -$49.17M— | —— | ||
| $3.16M-3.8% | $3.29M+212% | -$2.95M-207% | $2.74M— | ||
| —— | —— | —— | $0+100% | ||
| $36.37M+228% | -$28.5M+84.2% | -$180.15M+43.6% | -$319.16M-67.6% | ||
| $19.02M+246% | $5.49M+4.6% | $5.25M-26.6% | $7.16M-23.9% | ||
| $2.06M— | —— | $0— | —— | ||
| -$61.52M-104% | -$30.13M+31.1% | -$43.73M+69.1% | -$141.33M-580% | ||
| —— | —— | —— | $0-100% | ||
| $2.02M+413% | $394K— | —— | $197.66M-43.5% | ||
| $2.45M-10.2% | $2.73M-24.2% | $3.6M+9.3% | $3.29M— | ||
| $48.03M+8.7% | $44.16M-76.4% | $187.15M-5.5% | $197.96M-60.0% | ||
| $19.79M— | —— | —— | -$263.17M— | ||
| $6.41M-4.0% | $6.68M+120% | $3.04M+57.4% | $1.93M-29.8% | ||
| $1.28M+9.3% | $1.17M-20.3% | $1.47M+18.0% | $1.24M+256% | ||
| —— | $0-100% | $10.4M-95.1% | $210.15M— | ||
| —— | —— | $9.75M— | —— | ||
| $43.97M+7.1% | $41.06M+131% | $17.77M— | —— | ||
| $2.06M— | —— | $0— | —— | ||
| $2.45M-10.2% | $2.73M-24.2% | $3.6M+9.3% | $3.29M— | ||
| $46.83M+0.7% | $46.5M— | —— | $0— | ||
| —— | $2.61M— | —— | $0— | ||
| —— | $13.37M+1,243% | -$1.17M+98.3% | -$70.23M-697% | ||
| —— | $0-100% | $637K— | $0— | ||
| $0— | $0-100% | $6.69M— | $0— | ||
| —— | -$33.99M+81.7% | -$185.4M+43.2% | -$326.31M-63.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does GeneDx Holdings generate?
- GeneDx Holdings (WGS) generated -$6.2M in operating cash flow over the trailing twelve months.
- What is GeneDx Holdings's free cash flow?
- After $19.3M of capital expenditures, GeneDx Holdings's free cash flow was -$17.2M over the trailing twelve months, up 49.5% year over year.
- Where does GeneDx Holdings's cash flow data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
